Shanghai Shyndec Pharmaceutical Co Ltd (600420) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥486.04 Million ≈ $71.12 Million USD) by net assets (CN¥15.70 Billion ≈ $2.30 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Shanghai Shyndec Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
Shanghai Shyndec Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Shanghai Shyndec Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Shyndec Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Shyndec Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Shanghai Shyndec Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GIMV NV
BR:GIMB
|
-0.116x |
|
Gestamp Automocion SA
MC:GEST
|
0.122x |
|
Ruentex Engineering & Construction Co Ltd
TW:2597
|
-0.059x |
|
EQ Resources Ltd
AU:EQR
|
-0.169x |
|
Der International Home Furnishing Co Ltd
SHE:002631
|
-0.007x |
|
ORG Packaging Co Ltd
SHE:002701
|
0.068x |
|
Atrium Ljungberg AB (publ)
ST:ATRLJ-B
|
0.005x |
|
Anterix Inc
NASDAQ:ATEX
|
0.007x |
Annual Cash Flow Conversion Efficiency for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. View Shanghai Shyndec Pharmaceutical Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥34.93 Billion ≈ $5.11 Billion |
CN¥1.70 Billion ≈ $248.48 Million |
0.049x | -66.98% |
| 2024-12-31 | CN¥15.32 Billion ≈ $2.24 Billion |
CN¥2.26 Billion ≈ $330.12 Million |
0.147x | +22.71% |
| 2023-12-31 | CN¥14.34 Billion ≈ $2.10 Billion |
CN¥1.72 Billion ≈ $251.74 Million |
0.120x | -48.94% |
| 2022-12-31 | CN¥12.15 Billion ≈ $1.78 Billion |
CN¥2.86 Billion ≈ $417.87 Million |
0.235x | +45.07% |
| 2021-12-31 | CN¥10.37 Billion ≈ $1.52 Billion |
CN¥1.68 Billion ≈ $245.79 Million |
0.162x | +1.94% |
| 2020-12-31 | CN¥9.82 Billion ≈ $1.44 Billion |
CN¥1.56 Billion ≈ $228.30 Million |
0.159x | +15.13% |
| 2019-12-31 | CN¥9.20 Billion ≈ $1.35 Billion |
CN¥1.27 Billion ≈ $185.86 Million |
0.138x | -30.19% |
| 2018-12-31 | CN¥8.44 Billion ≈ $1.24 Billion |
CN¥1.67 Billion ≈ $244.25 Million |
0.198x | -34.68% |
| 2017-12-31 | CN¥7.65 Billion ≈ $1.12 Billion |
CN¥2.31 Billion ≈ $338.69 Million |
0.303x | +150.41% |
| 2016-12-31 | CN¥6.94 Billion ≈ $1.02 Billion |
CN¥838.58 Million ≈ $122.71 Million |
0.121x | -14.06% |
| 2015-12-31 | CN¥1.61 Billion ≈ $235.83 Million |
CN¥226.65 Million ≈ $33.17 Million |
0.141x | -24.27% |
| 2014-12-31 | CN¥1.39 Billion ≈ $203.72 Million |
CN¥258.51 Million ≈ $37.83 Million |
0.186x | +18.60% |
| 2013-12-31 | CN¥1.33 Billion ≈ $193.92 Million |
CN¥207.50 Million ≈ $30.36 Million |
0.157x | -3.62% |
| 2012-12-31 | CN¥1.19 Billion ≈ $174.21 Million |
CN¥193.41 Million ≈ $28.30 Million |
0.162x | +13.10% |
| 2011-12-31 | CN¥947.63 Million ≈ $138.67 Million |
CN¥136.12 Million ≈ $19.92 Million |
0.144x | +4.53% |
| 2010-12-31 | CN¥837.59 Million ≈ $122.57 Million |
CN¥115.11 Million ≈ $16.84 Million |
0.137x | +0.63% |
| 2009-12-31 | CN¥713.46 Million ≈ $104.40 Million |
CN¥97.43 Million ≈ $14.26 Million |
0.137x | +48.57% |
| 2008-12-31 | CN¥631.47 Million ≈ $92.40 Million |
CN¥58.04 Million ≈ $8.49 Million |
0.092x | -33.63% |
| 2007-12-31 | CN¥594.29 Million ≈ $86.96 Million |
CN¥82.31 Million ≈ $12.04 Million |
0.138x | -3.74% |
| 2006-12-31 | CN¥511.49 Million ≈ $74.85 Million |
CN¥73.60 Million ≈ $10.77 Million |
0.144x | +19.00% |
| 2005-12-31 | CN¥478.84 Million ≈ $70.07 Million |
CN¥57.90 Million ≈ $8.47 Million |
0.121x | +213.99% |
| 2004-12-31 | CN¥441.88 Million ≈ $64.66 Million |
CN¥17.02 Million ≈ $2.49 Million |
0.039x | -- |
About Shanghai Shyndec Pharmaceutical Co Ltd
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company provides nifedipine controlled release tablets, penicillin industrial potassium salt, touboke yuekui granules/capsules, sodium cefuroxime for injection, D-7ACA, fermented products, milnacipran hydrochloride tablets, compound licorice tablets, and… Read more